Literature DB >> 12463651

A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy.

Cassie Thomas1.   

Abstract

Tuberculosis is the cause of a large burden of disease in less developed countries. With the development of drug resistance and the co-epidemic of HIV, tuberculosis has already started to make a comeback in wealthier countries. The WHO's solution to this global tuberculosis epidemic is the DOTS strategy, the implementation of which presents many problems. The two issues most common to the majority of locations are delay in presentation for treatment and non-completion of treatment. This review looks at the reasons for these problems in the less developed world, and addresses some solutions. The main reasons for delayed presentation are: a lack of understanding about TB; the stigma associated with the disease; the inaccessibility of treatment; and a preference for private practitioners. The main reasons for non-completion of treatment are: the stigma of the disease; a lack of information; dissatisfaction with the treatment and its delivery; and inaccessibility of treatment. Successful implementations of the DOTS strategy need to address all these issues. There is little evidence that DOT enhances treatment completion unless combined with other strategies. Community-based, patient-orientated DOTS appears to be an appropriate way of addressing many of these issues. The involvement of volunteers in community-based strategies is common, but needs more research in order for this strategy to realise its full potential.

Entities:  

Mesh:

Year:  2002        PMID: 12463651     DOI: 10.1108/02689230210446544

Source DB:  PubMed          Journal:  J Manag Med        ISSN: 0268-9235


  12 in total

Review 1.  Systematic review of barriers to surgical care in low-income and middle-income countries.

Authors:  Caris E Grimes; Kendra G Bowman; Christopher M Dodgion; Christopher B D Lavy
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

2.  Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

Authors:  M Ballif; V Nhandu; R Wood; J C Dusingize; E J Carter; C P Cortes; C C McGowan; L Diero; C Graber; L Renner; D Hawerlander; S Kiertiburanakul; Q T Du; T R Sterling; M Egger; L Fenner
Journal:  Int J Tuberc Lung Dis       Date:  2014-11       Impact factor: 2.373

3.  Time of default in tuberculosis patients on directly observed treatment.

Authors:  Geeta S Pardeshi
Journal:  J Glob Infect Dis       Date:  2010-09

4.  Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery.

Authors:  Jean C Sung; Danielle J Padilla; Lucila Garcia-Contreras; Jarod L Verberkmoes; David Durbin; Charles A Peloquin; Katharina J Elbert; Anthony J Hickey; David A Edwards
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

5.  Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis.

Authors:  Andre Kipnis; Randall J Basaraba; Ian M Orme; Andrea M Cooper
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

6.  Access to tuberculosis diagnosis in Itaboraí City, Rio de Janeiro, Brazil: the patient's point of view.

Authors:  M C S Motta; T C S Villa; J Golub; A L Kritski; A Ruffino-Netto; D F Silva; R G Harter; L M Scatena
Journal:  Int J Tuberc Lung Dis       Date:  2009-09       Impact factor: 2.373

Review 7.  Pharmaceutical aerosols for the treatment and prevention of tuberculosis.

Authors:  Shumaila N M Hanif; Lucila Garcia-Contreras
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

8.  Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia.

Authors:  Estifanos Biru Shargie; Bernt Lindtjørn
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

9.  Determinants of tuberculosis treatment default in Morocco: results from a national cohort study.

Authors:  Nabil Tachfouti; Katia Slama; Mohamed Berraho; Samira Elfakir; Mohammed Chakib Benjelloun; Karima El Rhazi; Chakib Nejjari
Journal:  Pan Afr Med J       Date:  2013-03-28

10.  Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda, Angola.

Authors:  Luigi Segagni Lusignani; Gianluca Quaglio; Andrea Atzori; Joseph Nsuka; Ross Grainger; Maria Da Conceiçao Palma; Giovanni Putoto; Fabio Manenti
Journal:  BMC Infect Dis       Date:  2013-04-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.